Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Veenstra

Showing results (31-40 of 284) with videos related to

Pageof 29
Sort By:
AAPS Pharmsci|December 14, 2001
Assessing the cost-effectiveness of pharmacogenomicsD L Veenstra, M K Higashi, K A Phillips
Archives of Internal Medicine|May 12, 2004
The efficacy and safety of sibutramine for weight loss: a systematic reviewDavid E Arterburn, Paul K Crane, David L Veenstra
Journal of Chemical Ecology|November 30, 2006
Premating isolation is determined by larval rearing substrates in cactophilic Drosophila mojavensis. VII. Effects of larval dietary fatty acids on adult epicuticular hydrocarbonsWilliam J Etges, Christi L Veenstra, Larry L Jackson
Drugs|May 20, 2008
Pharmacoeconomic evaluations in the treatment of non-small cell lung cancerJosh J Carlson, David L Veenstra, Scott D Ramsey
Pharmacoeconomics|July 28, 2020
Cost-Effectiveness of Cannabidiol Adjunct Therapy versus Usual Care for the Treatment of Seizures in Lennox-Gastaut SyndromeEdward E Neuberger, Josh J Carlson, David L Veenstra
Protein Engineering|March 1, 1996
Free energy calculations of the mutation of Ile96-->Ala in barnase: contributions to the difference in stabilityY C Sun, D L Veenstra, P A Kollman
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Cost-consequences of ultrafiltration for acute heart failure: a decision model analysisSteven M Bradley, Wayne C Levy, David L Veenstra
Chest|July 16, 2011
Fondaparinux for isolated superficial vein thrombosis of the legs: a cost-effectiveness analysisMarc Blondon, Marc Righini, Henri Bounameaux, et al.
Nursing Outlook|September 28, 2014
Challenges in evaluating next-generation sequence data for clinical decisionsJanet K Williams, Ann K Cashion, David L Veenstra
Pharmacoeconomics|May 31, 2002
A guideline for the use of pharmacoeconomic models of diabetes treatment in the US managed-care environmentDavid L Veenstra, Scott D Ramsey, Sean D Sullivan
Pageof 29

Showing results (31-40 of 284) with videos related to

Sort By:
Pageof 29
AAPS Pharmsci|December 14, 2001
Assessing the cost-effectiveness of pharmacogenomicsD L Veenstra, M K Higashi, K A Phillips
Archives of Internal Medicine|May 12, 2004
The efficacy and safety of sibutramine for weight loss: a systematic reviewDavid E Arterburn, Paul K Crane, David L Veenstra
Journal of Chemical Ecology|November 30, 2006
Premating isolation is determined by larval rearing substrates in cactophilic Drosophila mojavensis. VII. Effects of larval dietary fatty acids on adult epicuticular hydrocarbonsWilliam J Etges, Christi L Veenstra, Larry L Jackson
Drugs|May 20, 2008
Pharmacoeconomic evaluations in the treatment of non-small cell lung cancerJosh J Carlson, David L Veenstra, Scott D Ramsey
Pharmacoeconomics|July 28, 2020
Cost-Effectiveness of Cannabidiol Adjunct Therapy versus Usual Care for the Treatment of Seizures in Lennox-Gastaut SyndromeEdward E Neuberger, Josh J Carlson, David L Veenstra
Protein Engineering|March 1, 1996
Free energy calculations of the mutation of Ile96-->Ala in barnase: contributions to the difference in stabilityY C Sun, D L Veenstra, P A Kollman
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Cost-consequences of ultrafiltration for acute heart failure: a decision model analysisSteven M Bradley, Wayne C Levy, David L Veenstra
Chest|July 16, 2011
Fondaparinux for isolated superficial vein thrombosis of the legs: a cost-effectiveness analysisMarc Blondon, Marc Righini, Henri Bounameaux, et al.
Nursing Outlook|September 28, 2014
Challenges in evaluating next-generation sequence data for clinical decisionsJanet K Williams, Ann K Cashion, David L Veenstra
Pharmacoeconomics|May 31, 2002
A guideline for the use of pharmacoeconomic models of diabetes treatment in the US managed-care environmentDavid L Veenstra, Scott D Ramsey, Sean D Sullivan
Pageof 29